APA (7th ed.) Citation

Soegiharto, R., Alizadeh Aghdam, M., Sørensen, J. A., van Lindonk, E., Bulut Demir, F., Mohammad Porras, N., . . . Giménez‐Arnau, A. M. (2025). Omalizumab is effective and safe in chronic inducible urticaria (CIndU): Real‐world data from a large multi‐national UCARE study. Allergy, 80(2), 489. https://doi.org/10.1111/all.16334

Chicago Style (17th ed.) Citation

Soegiharto, R., et al. "Omalizumab Is Effective and Safe in Chronic Inducible Urticaria (CIndU): Real‐world Data from a Large Multi‐national UCARE Study." Allergy 80, no. 2 (2025): 489. https://doi.org/10.1111/all.16334.

MLA (9th ed.) Citation

Soegiharto, R., et al. "Omalizumab Is Effective and Safe in Chronic Inducible Urticaria (CIndU): Real‐world Data from a Large Multi‐national UCARE Study." Allergy, vol. 80, no. 2, 2025, p. 489, https://doi.org/10.1111/all.16334.